TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines March 12, 1976
TCL Archive Cancer Centers: John Glick to step down after 21 years directing Penn’s Abramson Cancer Center. December 2, 2005
TCL Archive In Brief: NCAB To Hear NCI Staff Plans For Implementing Recommendation On Nutrition & Cancer Task Force October 1, 1982